Synthesis and 125I labeling of a precursor for imaging nicotinic acetylcholine receptors
Yuxia LIU,Ning LIU,Yuanyou YANG,Liangbiao ZAN,Jiali LIAO,Jiannan JIN
DOI: https://doi.org/10.3321/j.issn:0253-3219.2006.08.008
2006-01-01
Abstract:Nicotinic Acetylcholine Receptors (nAChRs) are involved in various pharmacological effects or diseases, such as Alzheimer's Disease, Parkinson's Disease and tobacco addiction. It will be very appealing to image nAChRs in vivo, diagnose and treat the above diseases, and probe the mechanism of nAChRs in tobacco addiction if the suitable radioactive labeled compound can be synthesized. In this study, (s)-5-(tri-butylstannyl)-3{[1-(tert-butoxycarbonyl)-2- azetidinyl]methoxy}pyridine, a precursor for imaging nAChRs, was synthesized with commercial 2-furfurylamine and (s)-2-azetidinecarboxylic acid as starting materials, and was further labeled with 125/123I.The whole procedure for radiosynthesis needs 50 - 55 min and more than 30% of the 125I are found in the purified 5-[125I]-A-85380. Even staying for 3 days at room temperature in vitro, the purified 5-[125I]-I-85380 can maintain its stability, with a radiochemical purity of more than 95%.